Who is This Guy?(History of Pharm)
Add Me on UptoDate (ADME)
Drive-Bys and Sponges (Routes and Absorption)
Intent to Sell (Distribution)
Two Dumb Men + Pretty Women (TDM + PK)
100

This physician is considered the Father of Immunology after demonstrating that cowpox protected against smallpox

Who is Edward Jenner?
100

This pharmacokinetic process describes movement of a drug from its site of administration into the bloodstream

What is Absorption?

100

This route has an F=1 

Intravenous (IV)

100

Lipophilic drugs generally have a _________ Vd

What is Large?
100

Phase 1 metabolism is primarily associated with this enzyme system

What is Cytochrome P450?
200

This guy accidentally created the first mass-produced "wonder drug"

Who is Alexander Fleming?

200

This pharmacokinetic process mainly occurs in the liver and generally makes drugs more soluble

What is metabolism?

200

This oral phenomenon decreases F because drugs are metabolized before reaching systemic circulation

What is First-Pass metabolism?

200

This major plasma protein is responsible for binding many drugs 

What is albumin?

200
An enzyme inhibitor generally causes drug concentrations to do this

What is increase?

300

This 1937 tragedy led directly to the passage of the landmark Food, Drug and Cosmetic Act of 1938 which called for pure and safe drugs.

What is the 1937 Elixir Sulfanilamide tragedy?

300

This pharmacokinetic process is primarily carried out by the kidneys and removes drugs from the body

Excretion

300

These two "oral" routes bypass significant first-pass metabolism and provide rapid absorption

Sublingual and buccal

300

Only this type of drug is pharmacologically active and able to leave the bloodstream

What is a free (unbound) drug?
300

This pharmacokinetic parameter is the time required for plasma drug concentration to decrease by 50% and ~4-5 of these is when the drug is mostly eliminated. 

What is a half-life?

400

This amendment required manufacturers to conduct adequate, well-designed clinicals and obtain informed consent.

The 1962 Kefauver-Harris Drug Amendments

400

DAILY DOUBLE 1!!!

Place the following steps of urine formation in the correct order:

  • PCT- Tubular secretion
  • Collecting Duct- Excretion
  • Glomerulus- Glomerular filtration
  • DCT- Tubular reabsorption
400

This is a primary site of absorption because of its large surface area

What is the small intestine?

400

This barrier limits drug entry into the CNS and contains efflux pumps

What is the Blood-Brain Barrier (BBB)?
400

A patient has been taking a medication with a 12-hour half-life at the same dose and interval. The provider wants to check a therapeutic drug level.

Approximately when should the drug be at steady state?

What is after approximately 4–5 half-lives, or about 48–60 hours?

500

4 Steps: 

1. Find microorganisms in abundance in diseased organisms

2. Isolate microorganisms and culture 

3. Reintroduce grown culture to healthy host

4. Reisolate microorganism from new host 

What are Koch's Postulates?

500

A drug is described as:

1. Highly lipophilic

2. Extensively metabolized in the liver

3. Excreted primarily as metabolites in the urine

Identify the ADME step represented by each of these characteristics.

What is D, M, E?


1. Lipophilic → Distribution

2. Liver metabolism → Metabolism

3. Urinary excretion of metabolites → Excretion

500

A patient is actively vomiting and cannot swallow medication. The provider wants rapid systemic drug absorption while avoiding significant first-pass metabolism. Based on the lecture, name 2 administration routes that would accomplish this goal.

What are IV, and SL?



Also acceptable, INH and IM

500

A highly protein-bound medication is given with another drug that displaces it from albumin. According to the lecture, what happens to the amount of pharmacologically active drug?

What is an increase in free (unbound) drug available to distribute into tissues and produce effects?

500

DAILY DOUBLE 2!

Two patients receive the same maintenance dose of gentamicin. Patient A develops acute kidney injury during therapy, while Patient B maintains normal renal function. Without changing the dose, what would you expect to happen to Patient A's trough concentration, and what pharmacokinetic principle explains it?